Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
459.81
-0.20 (-0.04%)
At close: Oct 15, 2026, 4:00 PM EDT
461.69
+1.88 (0.41%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Madrigal Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $669 → $735 | Buy | Maintains | $669 → $735 | +59.85% | Oct 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $685 | Buy | Maintains | $685 | +48.97% | Oct 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +34.84% | Oct 9, 2026 |
| Barclays | Barclays | Buy Maintains $962 | Buy | Maintains | $962 | +109.22% | Sep 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $704 | Buy | Initiates | $704 | +53.11% | Sep 24, 2026 |
| Citi | Citi | Buy Initiates $725 | Buy | Initiates | $725 | +57.67% | Sep 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $612 | Buy | Reiterates | $612 | +33.10% | Aug 12, 2026 |
| Wolfe Research | Wolfe Research | Buy Upgrades $605 | Buy | Upgrades | $605 | +31.58% | Aug 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.